A COMPARISON OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACT WITH DRUGS AND COSMETICS ACT: SALIENT DIFFERENCES

Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 3

Abstract

This article assesses the comparison of Narcotic Drugs and Psychotropic Substances Act (NDPS Act) with the Drug and Cosmetic Act (D & C Act) and also point out the salient features of NDPS Act. Drugs and Cosmetics Act, 1940 is a life-saving statue. It was enacted with an objective to regulate the import, manufacture, distribution and sale of drugs and cosmetics without licensing. Domestic legislation for regulating narcotic drugs and psychotropic substances in India has come in the form of NDPS Act, 1985, with an objective to limit the use of these substances and to prevent the abuse of these drugs. Both the aforesaid acts regulate narcotic drugs and psychotropic substances but the NDPS Act is special and strictest legislation for these substances. Stringent provisions of this act are examined in depth like minimum mandatory sentence of ten years and fine of one lakh rupees, offences are cognizable and non-bailable, consumption of drugs is also punishable offence, death sentence for certain repeat offences, attempt to commit an offence would be punishable with similar sentence as provided for that offence, power to tender immunity from prosecution, etc. In this article the authors provides some necessary recommendations in D & C Act on the basis of NDPS Act and also highlights some lacunas in both acts which need to be overcome.

Authors and Affiliations

Vikaas Budhwaar, Vaishali Pruthi, Arun Nanda, Manjusha Choudhary, Prateek G

Keywords

Related Articles

Nanoparticles and target Drug delivery for cancer treatment: A Comprehensive review

In the healthcare industry, the biggest challenges are cancer. However, there are several drugs are available for the treatment of cancer. In these treatments cure cancer affecting the collateral toxicity to healthy cell...

A Comprehensive and Comparative study of qualification process for Drug Development tools in US, Europe, Japan and India

Drug Development Tools are methods, materials, or measures that have the potential to facilitate drug development. USFDA has specified three major drug development tools and has also given the guidelines recommending the...

PHARMACEUTICAL QUALITY MANAGEMENT SYSTEM: A REVIEW

ICH is “International Conference on Harmonization” of technical requirements for registration of pharmaceuticals for human use. The goal of ICH is to discuss and establish common guidelines by bringing together three ICH...

FORMULATION AND DEVELOPMENT OF KETOPROFEN BILAYER TABLETS

Aim of present research work was formulation and development of bilayer tablets of Ketoprofen to reduce the side effects of Ketoprofen and to improve the therapeutic benefits and patients’ compliance to treatment. Bi-lay...

GERMANY PATENT SYSTEM – AN OVERVIEW

Patent is one of the intellectual property rights, by which the innovator gets exclusive rights or legal monopoly grated to an individual or a firm to make use or sell or reproduce and excluding others from doing so. The...

Download PDF file
  • EP ID EP326754
  • DOI 10.22270/ijdra.v5i3.202
  • Views 133
  • Downloads 0

How To Cite

Vikaas Budhwaar, Vaishali Pruthi, Arun Nanda, Manjusha Choudhary, Prateek G (2017). A COMPARISON OF NARCOTIC DRUGS AND PSYCHOTROPIC SUBSTANCES ACT WITH DRUGS AND COSMETICS ACT: SALIENT DIFFERENCES. International Journal of Drug Regulatory Affairs, 5(3), 10-19. https://europub.co.uk/articles/-A-326754